临床批准的针对血液癌症的免疫毒素:"两个世界中的最佳"
Yasmine Rashad1,2, Eckhard U Alt1, Reza Izadpanah1
1Applied Stem Cell Laboratory, Department of Medicine, Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, United States.
Frontiers in pharmacology
|November 3, 2025
概括
再组合免疫毒素 (RITs) 为血液癌症提供向癌症治疗,如毛细胞白血病和形血细胞状树突细胞瘤. 这些工程蛋白在治疗不耐药/复发性血液性恶性瘤方面表现出有效性.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 血液学 血液学 血液学
背景情况:
- 血液性恶性瘤是全球癌症负担的一个重要因素.
- 化学疗法和放射治疗等传统治疗方法面临的局限性包括耐药性,复发性和毒性.
- 再组合免疫毒素 (RIT) 已被开发为向疗法,将细胞毒性有效载荷与特定的瘤结合域结合起来.
研究的目的:
- 审查三种FDA批准的RIT:莫克塞图马布帕苏多托克斯,塔格拉克索福斯普和denileukindiftitox.
- 分析这些RIT的安全概况和并发症.
- 讨论风险管理策略,以提高RIT的临床结果.
主要方法:
- 由FDA批准的RITs的文献审查.
- 对与moxetumomab pasudotox,tagraxofusp和denileukin diftitox相关的安全数据和不良事件的分析.
- 对抗性/复发性血液性恶性瘤中RIT的临床结果和管理策略的检查.
主要成果:
- 莫克塞图莫马布 (Moxetumomab) 帕苏多托克斯 (Pasudotox),塔格拉克索福斯普 (Tagraxofusp) 和德尼莱乌金 (Denileukin) 迪夫蒂托克斯 (Diftitox) 是FDA批准的使用细菌毒素的RIT.
- 这些RIT针对特定的血液性恶性瘤,包括毛状细胞白血病,青性血细胞状树突细胞瘤和皮肤T细胞淋巴瘤.
- 该审查详细介绍了他们的安全概况,相关并发症和潜在的风险管理方法.
结论:
- RITs在治疗不耐药/复发性血液性恶性瘤方面表现出显著的疗效.
- 了解和管理与RIT相关的并发症对于优化患者治疗结果至关重要.
- 目前正在进行的研究旨在将RIT的应用扩展到其他癌症征兆.
关键词:
E77777777 E777777777777 E7777777777 E77777777 E77777777 E777777 E77777777 E77777777 E777777 E777777 E777777 E777777 E77777777 E77777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E777777 E77777 E77777 E77777 E777 E777 E777伪蒙的外毒素 伪蒙的外毒素癌症免疫疗法免疫疗法甲状腺炎毒素的毒素是什么血液学的恶性瘤.莫克塞图莫马布帕苏多托克斯复合免疫毒素的复合免疫毒素在Tagraxofusp中使用.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:30Cancer Vaccines
945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945